| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocephalus | 42 | 2024 | 766 | 15.960 |
Why?
|
| Symporters | 33 | 2022 | 363 | 6.950 |
Why?
|
| Hydrocephalus, Normal Pressure | 7 | 2024 | 101 | 4.260 |
Why?
|
| Chlorides | 21 | 2022 | 666 | 3.240 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 21 | 2016 | 106 | 3.120 |
Why?
|
| Brain Edema | 15 | 2023 | 601 | 2.340 |
Why?
|
| Neural Stem Cells | 9 | 2024 | 895 | 2.310 |
Why?
|
| Choroid Plexus | 6 | 2024 | 249 | 2.290 |
Why?
|
| Craniosynostoses | 7 | 2024 | 415 | 2.280 |
Why?
|
| Cerebral Ventricles | 10 | 2023 | 550 | 2.170 |
Why?
|
| Arachnoid Cysts | 3 | 2023 | 59 | 2.170 |
Why?
|
| Ion Transport | 14 | 2017 | 322 | 2.080 |
Why?
|
| Vein of Galen Malformations | 3 | 2023 | 57 | 1.980 |
Why?
|
| Cerebral Aqueduct | 3 | 2024 | 39 | 1.600 |
Why?
|
| Bumetanide | 10 | 2017 | 101 | 1.500 |
Why?
|
| Moyamoya Disease | 4 | 2023 | 274 | 1.500 |
Why?
|
| Neurosurgical Procedures | 12 | 2023 | 2077 | 1.380 |
Why?
|
| Arnold-Chiari Malformation | 5 | 2023 | 159 | 1.230 |
Why?
|
| gamma-Aminobutyric Acid | 9 | 2021 | 1139 | 1.220 |
Why?
|
| Cerebrospinal Fluid | 6 | 2024 | 540 | 1.180 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2024 | 386 | 1.180 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 8 | 2016 | 157 | 1.170 |
Why?
|
| Intracranial Hypertension | 3 | 2024 | 191 | 1.140 |
Why?
|
| Mutation | 33 | 2024 | 30214 | 1.120 |
Why?
|
| Brain Injuries | 8 | 2020 | 2053 | 1.060 |
Why?
|
| Brain | 36 | 2024 | 27158 | 1.060 |
Why?
|
| Brain Diseases | 4 | 2023 | 1552 | 1.060 |
Why?
|
| Neurogenesis | 7 | 2024 | 863 | 0.980 |
Why?
|
| Epilepsy | 9 | 2023 | 3317 | 0.940 |
Why?
|
| Cilia | 4 | 2024 | 498 | 0.940 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 3 | 2021 | 44 | 0.920 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 1478 | 0.900 |
Why?
|
| Homeostasis | 10 | 2017 | 3343 | 0.890 |
Why?
|
| Cranial Sutures | 2 | 2023 | 92 | 0.890 |
Why?
|
| p120 GTPase Activating Protein | 2 | 2023 | 35 | 0.870 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2021 | 713 | 0.830 |
Why?
|
| Neuroendoscopy | 2 | 2023 | 100 | 0.820 |
Why?
|
| Synaptic Transmission | 5 | 2021 | 1175 | 0.820 |
Why?
|
| Third Ventricle | 1 | 2023 | 78 | 0.820 |
Why?
|
| Skull | 3 | 2023 | 819 | 0.800 |
Why?
|
| Humans | 191 | 2024 | 766812 | 0.790 |
Why?
|
| Receptor, EphB4 | 2 | 2019 | 39 | 0.790 |
Why?
|
| Neurons | 18 | 2024 | 9515 | 0.770 |
Why?
|
| Animals | 91 | 2024 | 168939 | 0.770 |
Why?
|
| Molecular Targeted Therapy | 4 | 2020 | 2823 | 0.770 |
Why?
|
| Signal Transduction | 28 | 2023 | 23618 | 0.760 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.760 |
Why?
|
| Cell Size | 8 | 2019 | 625 | 0.730 |
Why?
|
| Cerebral Hemorrhage | 4 | 2024 | 2654 | 0.720 |
Why?
|
| Decompressive Craniectomy | 4 | 2020 | 76 | 0.700 |
Why?
|
| Trigeminal Neuralgia | 2 | 2019 | 103 | 0.700 |
Why?
|
| Hematoma, Subdural, Spinal | 1 | 2019 | 8 | 0.670 |
Why?
|
| Microcephaly | 1 | 2024 | 427 | 0.670 |
Why?
|
| Neuralgia | 3 | 2016 | 618 | 0.660 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2019 | 30 | 0.660 |
Why?
|
| Neocortex | 1 | 2023 | 414 | 0.650 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2023 | 390 | 0.650 |
Why?
|
| Spinal Cord Compression | 2 | 2019 | 234 | 0.640 |
Why?
|
| Ephrin-B2 | 1 | 2019 | 40 | 0.640 |
Why?
|
| Cerebrospinal Fluid Shunts | 5 | 2024 | 197 | 0.630 |
Why?
|
| Campomelic Dysplasia | 1 | 2018 | 2 | 0.620 |
Why?
|
| Phosphorylation | 21 | 2022 | 8310 | 0.620 |
Why?
|
| Ventriculostomy | 4 | 2024 | 132 | 0.600 |
Why?
|
| Molecular Motor Proteins | 1 | 2018 | 105 | 0.600 |
Why?
|
| Nervous System Diseases | 6 | 2015 | 1659 | 0.580 |
Why?
|
| Chromosome Duplication | 1 | 2017 | 79 | 0.580 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 145 | 0.570 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 588 | 0.570 |
Why?
|
| Seizures | 9 | 2021 | 2996 | 0.560 |
Why?
|
| Neurosurgery | 1 | 2023 | 682 | 0.560 |
Why?
|
| Fourth Ventricle | 1 | 2017 | 32 | 0.550 |
Why?
|
| Intracranial Pressure | 3 | 2021 | 323 | 0.540 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 403 | 0.540 |
Why?
|
| Neurofibromatosis 2 | 1 | 2020 | 387 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 534 | 0.540 |
Why?
|
| Anticonvulsants | 6 | 2020 | 1921 | 0.540 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 456 | 0.530 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2022 | 1900 | 0.520 |
Why?
|
| Encephalitis | 1 | 2020 | 441 | 0.520 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 187 | 0.520 |
Why?
|
| Spinal Nerves | 1 | 2016 | 92 | 0.510 |
Why?
|
| Mutation, Missense | 5 | 2023 | 2591 | 0.500 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.490 |
Why?
|
| Neuroglia | 3 | 2020 | 960 | 0.480 |
Why?
|
| Spinal Diseases | 3 | 2023 | 561 | 0.480 |
Why?
|
| Ependyma | 4 | 2024 | 57 | 0.480 |
Why?
|
| Family Health | 2 | 2017 | 1254 | 0.480 |
Why?
|
| Pyrrolidines | 1 | 2016 | 339 | 0.470 |
Why?
|
| Hydrodynamics | 3 | 2024 | 164 | 0.470 |
Why?
|
| Minor Histocompatibility Antigens | 9 | 2016 | 303 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 632 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2023 | 18076 | 0.450 |
Why?
|
| Hyperalgesia | 2 | 2016 | 527 | 0.450 |
Why?
|
| Brain Ischemia | 5 | 2016 | 3001 | 0.440 |
Why?
|
| Scoliosis | 4 | 2021 | 793 | 0.430 |
Why?
|
| Hemangioma | 1 | 2018 | 727 | 0.420 |
Why?
|
| Diuretics, Osmotic | 1 | 2012 | 32 | 0.420 |
Why?
|
| Neural Inhibition | 2 | 2014 | 589 | 0.420 |
Why?
|
| Craniotomy | 6 | 2019 | 736 | 0.410 |
Why?
|
| Molecular Biology | 4 | 2023 | 573 | 0.400 |
Why?
|
| Mice | 44 | 2024 | 81898 | 0.400 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1392 | 0.400 |
Why?
|
| Length of Stay | 6 | 2021 | 6491 | 0.400 |
Why?
|
| Transcription Factors | 7 | 2024 | 12159 | 0.400 |
Why?
|
| Spinal Fusion | 6 | 2021 | 1307 | 0.390 |
Why?
|
| Epilepsy, Generalized | 1 | 2014 | 181 | 0.390 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 1368 | 0.380 |
Why?
|
| Infant | 18 | 2024 | 36459 | 0.380 |
Why?
|
| Membrane Transport Proteins | 3 | 2024 | 1029 | 0.380 |
Why?
|
| Imidazoles | 2 | 2018 | 1168 | 0.380 |
Why?
|
| Blood-Brain Barrier | 4 | 2023 | 1028 | 0.370 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2012 | 144 | 0.370 |
Why?
|
| Rhombencephalon | 1 | 2011 | 81 | 0.370 |
Why?
|
| Disease | 1 | 2017 | 675 | 0.370 |
Why?
|
| Meningioma | 1 | 2020 | 1221 | 0.370 |
Why?
|
| Diffuse Axonal Injury | 1 | 2011 | 49 | 0.370 |
Why?
|
| Xenopus laevis | 11 | 2021 | 966 | 0.370 |
Why?
|
| Child | 29 | 2024 | 80670 | 0.370 |
Why?
|
| Motor Neurons | 1 | 2016 | 869 | 0.370 |
Why?
|
| Female | 75 | 2024 | 396532 | 0.370 |
Why?
|
| Syringomyelia | 1 | 2011 | 66 | 0.370 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2023 | 186 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2024 | 2887 | 0.360 |
Why?
|
| Chloride Channels | 4 | 2023 | 221 | 0.360 |
Why?
|
| Pyramidal Cells | 4 | 2024 | 367 | 0.360 |
Why?
|
| Potassium | 6 | 2021 | 1314 | 0.360 |
Why?
|
| Receptors, GABA-A | 4 | 2017 | 624 | 0.360 |
Why?
|
| Ions | 2 | 2017 | 254 | 0.360 |
Why?
|
| Progesterone | 1 | 2015 | 752 | 0.360 |
Why?
|
| Neurologic Examination | 2 | 2013 | 913 | 0.360 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 1110 | 0.350 |
Why?
|
| Transportation of Patients | 1 | 2011 | 177 | 0.350 |
Why?
|
| Activin Receptors, Type II | 2 | 2023 | 122 | 0.350 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8715 | 0.350 |
Why?
|
| Air Ambulances | 1 | 2011 | 93 | 0.350 |
Why?
|
| Cost of Illness | 1 | 2020 | 1949 | 0.350 |
Why?
|
| Headache | 3 | 2022 | 1260 | 0.350 |
Why?
|
| Male | 74 | 2024 | 364154 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 36570 | 0.340 |
Why?
|
| Spinal Cord | 2 | 2018 | 1811 | 0.340 |
Why?
|
| Intracranial Aneurysm | 6 | 2021 | 1271 | 0.340 |
Why?
|
| Kidney | 7 | 2014 | 7073 | 0.340 |
Why?
|
| NF-kappa B | 2 | 2022 | 2493 | 0.340 |
Why?
|
| Scalp | 4 | 2021 | 390 | 0.330 |
Why?
|
| Xenopus | 5 | 2020 | 710 | 0.330 |
Why?
|
| Receptors, Drug | 3 | 2012 | 156 | 0.330 |
Why?
|
| Papilledema | 1 | 2011 | 130 | 0.330 |
Why?
|
| Pseudotumor Cerebri | 1 | 2011 | 107 | 0.330 |
Why?
|
| TRPM Cation Channels | 3 | 2023 | 140 | 0.310 |
Why?
|
| Stroke | 9 | 2022 | 9744 | 0.300 |
Why?
|
| Cell Membrane Permeability | 3 | 2014 | 568 | 0.300 |
Why?
|
| Drug Discovery | 2 | 2020 | 1065 | 0.290 |
Why?
|
| Blast Injuries | 1 | 2011 | 318 | 0.290 |
Why?
|
| Lateral Ventricles | 2 | 2018 | 142 | 0.290 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 453 | 0.280 |
Why?
|
| Membrane Potentials | 4 | 2019 | 1085 | 0.280 |
Why?
|
| Analgesics | 1 | 2014 | 1068 | 0.280 |
Why?
|
| Hypertension | 12 | 2022 | 8616 | 0.280 |
Why?
|
| Cohort Studies | 12 | 2024 | 41706 | 0.280 |
Why?
|
| Dura Mater | 3 | 2020 | 292 | 0.270 |
Why?
|
| Chlorine | 1 | 2006 | 55 | 0.270 |
Why?
|
| Water-Electrolyte Balance | 1 | 2008 | 326 | 0.270 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2018 | 474 | 0.270 |
Why?
|
| Inflammation | 4 | 2021 | 10863 | 0.260 |
Why?
|
| Oocytes | 10 | 2021 | 1168 | 0.250 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2019 | 263 | 0.250 |
Why?
|
| Blood Pressure | 5 | 2013 | 8533 | 0.250 |
Why?
|
| Sodium | 2 | 2010 | 1594 | 0.250 |
Why?
|
| Phenotype | 4 | 2021 | 16722 | 0.250 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1794 | 0.250 |
Why?
|
| Quebec | 2 | 2016 | 140 | 0.240 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3698 | 0.240 |
Why?
|
| Pseudohypoaldosteronism | 5 | 2010 | 7 | 0.240 |
Why?
|
| Epilepsia Partialis Continua | 1 | 2024 | 25 | 0.240 |
Why?
|
| Infant, Newborn | 10 | 2024 | 26387 | 0.230 |
Why?
|
| Hospitals | 3 | 2021 | 3885 | 0.230 |
Why?
|
| Treatment Outcome | 22 | 2023 | 65286 | 0.230 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 1276 | 0.230 |
Why?
|
| Mice, 129 Strain | 3 | 2019 | 367 | 0.220 |
Why?
|
| Foramen Magnum | 1 | 2023 | 41 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2023 | 1244 | 0.220 |
Why?
|
| Postoperative Complications | 9 | 2021 | 15831 | 0.220 |
Why?
|
| Osmotic Pressure | 2 | 2016 | 136 | 0.220 |
Why?
|
| Cutis Laxa | 1 | 2023 | 29 | 0.210 |
Why?
|
| Epithelium | 3 | 2004 | 1606 | 0.210 |
Why?
|
| MicroRNAs | 1 | 2019 | 3789 | 0.210 |
Why?
|
| Diuretics | 3 | 2017 | 614 | 0.210 |
Why?
|
| Aquaporin 4 | 2 | 2023 | 161 | 0.210 |
Why?
|
| Lumbar Vertebrae | 4 | 2019 | 1878 | 0.200 |
Why?
|
| Cell Polarity | 2 | 2014 | 637 | 0.200 |
Why?
|
| Pedigree | 3 | 2018 | 4539 | 0.200 |
Why?
|
| Brain Neoplasms | 7 | 2021 | 9101 | 0.200 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2022 | 42 | 0.200 |
Why?
|
| Models, Biological | 4 | 2014 | 9464 | 0.200 |
Why?
|
| Cyclophilins | 1 | 2021 | 47 | 0.200 |
Why?
|
| Military Personnel | 1 | 2011 | 1260 | 0.200 |
Why?
|
| Tight Junctions | 1 | 2004 | 324 | 0.190 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2016 | 484 | 0.190 |
Why?
|
| Hospitalization | 3 | 2021 | 10816 | 0.190 |
Why?
|
| Pregnancy | 6 | 2024 | 30236 | 0.190 |
Why?
|
| Biology | 1 | 2024 | 292 | 0.190 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 1279 | 0.190 |
Why?
|
| Sodium Chloride | 1 | 2003 | 580 | 0.190 |
Why?
|
| Animals, Newborn | 5 | 2019 | 2677 | 0.190 |
Why?
|
| Forecasting | 2 | 2023 | 2936 | 0.190 |
Why?
|
| Sodium Chloride Symporters | 5 | 2009 | 10 | 0.190 |
Why?
|
| Child, Preschool | 11 | 2024 | 42577 | 0.180 |
Why?
|
| Genomics | 3 | 2021 | 5922 | 0.180 |
Why?
|
| Rats | 14 | 2017 | 23717 | 0.180 |
Why?
|
| Receptors, Virus | 1 | 2024 | 652 | 0.180 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 467 | 0.180 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14473 | 0.180 |
Why?
|
| Pathology, Molecular | 1 | 2023 | 329 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2024 | 628 | 0.180 |
Why?
|
| Cerebral Arteries | 1 | 2023 | 490 | 0.170 |
Why?
|
| Laminectomy | 2 | 2019 | 226 | 0.170 |
Why?
|
| Hyperkalemia | 5 | 2009 | 233 | 0.170 |
Why?
|
| Tretinoin | 1 | 2023 | 524 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2011 | 1543 | 0.170 |
Why?
|
| Penetrance | 2 | 2018 | 388 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2882 | 0.170 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2020 | 43 | 0.170 |
Why?
|
| Genetic Variation | 3 | 2021 | 6613 | 0.170 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1886 | 0.170 |
Why?
|
| Genes, Switch | 1 | 2019 | 48 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2014 | 5388 | 0.170 |
Why?
|
| Mice, Transgenic | 7 | 2019 | 9546 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 258 | 0.160 |
Why?
|
| Retrospective Studies | 20 | 2023 | 81657 | 0.160 |
Why?
|
| Myelin Sheath | 2 | 2021 | 650 | 0.160 |
Why?
|
| Animal Fins | 1 | 2019 | 23 | 0.160 |
Why?
|
| Spinal Neoplasms | 2 | 2019 | 714 | 0.160 |
Why?
|
| Hyperhidrosis | 1 | 2019 | 34 | 0.160 |
Why?
|
| Meningomyelocele | 1 | 2021 | 182 | 0.160 |
Why?
|
| Ephrins | 1 | 2018 | 28 | 0.160 |
Why?
|
| Hippocampus | 4 | 2023 | 3776 | 0.160 |
Why?
|
| Larva | 1 | 2020 | 511 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2016 | 4277 | 0.160 |
Why?
|
| Blotting, Western | 5 | 2017 | 5022 | 0.160 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2020 | 120 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5860 | 0.160 |
Why?
|
| Microtubules | 1 | 2024 | 1063 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2021 | 1505 | 0.150 |
Why?
|
| Skeleton | 1 | 2018 | 29 | 0.150 |
Why?
|
| Binding Sites | 2 | 2019 | 6013 | 0.150 |
Why?
|
| Drugs, Investigational | 1 | 2020 | 211 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3886 | 0.150 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2020 | 211 | 0.150 |
Why?
|
| Diskectomy | 2 | 2018 | 203 | 0.150 |
Why?
|
| Ganglioglioma | 1 | 2018 | 36 | 0.150 |
Why?
|
| Drug Repositioning | 1 | 2020 | 246 | 0.150 |
Why?
|
| Biological Transport | 2 | 2017 | 2083 | 0.150 |
Why?
|
| Decompression, Surgical | 2 | 2020 | 603 | 0.150 |
Why?
|
| Salicylanilides | 1 | 2017 | 15 | 0.150 |
Why?
|
| Thiocarbamates | 1 | 2017 | 30 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2021 | 1751 | 0.140 |
Why?
|
| Gene Duplication | 1 | 2018 | 315 | 0.140 |
Why?
|
| Organ Size | 2 | 2019 | 2262 | 0.140 |
Why?
|
| Myxoma | 1 | 2018 | 114 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2016 | 6976 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2210 | 0.140 |
Why?
|
| Acetazolamide | 1 | 2017 | 98 | 0.140 |
Why?
|
| Patients | 1 | 2023 | 908 | 0.140 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 386 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 3 | 2014 | 810 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 348 | 0.140 |
Why?
|
| Vision Disorders | 2 | 2022 | 1090 | 0.130 |
Why?
|
| Syndrome | 1 | 2023 | 3271 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 2021 | 1206 | 0.130 |
Why?
|
| RNA Interference | 3 | 2016 | 2829 | 0.130 |
Why?
|
| Nitriles | 3 | 2020 | 981 | 0.130 |
Why?
|
| Astrocytoma | 1 | 2021 | 773 | 0.130 |
Why?
|
| Adult | 23 | 2023 | 223305 | 0.130 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2018 | 330 | 0.130 |
Why?
|
| Adolescent | 16 | 2021 | 88902 | 0.130 |
Why?
|
| Spine | 3 | 2019 | 1134 | 0.130 |
Why?
|
| Mammals | 1 | 2021 | 1133 | 0.130 |
Why?
|
| Rats, Wistar | 2 | 2017 | 1887 | 0.130 |
Why?
|
| Joint Instability | 1 | 2023 | 803 | 0.130 |
Why?
|
| Glioma | 3 | 2017 | 3498 | 0.130 |
Why?
|
| Cerebral Ventriculitis | 1 | 2015 | 7 | 0.130 |
Why?
|
| Astrocytes | 2 | 2023 | 1351 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 8 | 2022 | 22351 | 0.130 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 2045 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1117 | 0.130 |
Why?
|
| Proline | 1 | 2017 | 454 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 283 | 0.120 |
Why?
|
| Young Adult | 12 | 2023 | 59939 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1604 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2018 | 1150 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 346 | 0.120 |
Why?
|
| Self-Injurious Behavior | 1 | 2021 | 571 | 0.120 |
Why?
|
| Genes, ras | 1 | 2018 | 656 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1612 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 18329 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1331 | 0.120 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 874 | 0.120 |
Why?
|
| Mucormycosis | 1 | 2016 | 104 | 0.120 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2014 | 12 | 0.120 |
Why?
|
| Thoracic Vertebrae | 1 | 2019 | 613 | 0.120 |
Why?
|
| Middle Aged | 23 | 2023 | 223267 | 0.120 |
Why?
|
| Microsurgery | 2 | 2018 | 798 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 26309 | 0.110 |
Why?
|
| Spinal Cord Injuries | 2 | 2013 | 927 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 804 | 0.110 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 1023 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2020 | 2253 | 0.110 |
Why?
|
| Age of Onset | 1 | 2021 | 3343 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2017 | 1647 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2019 | 18986 | 0.110 |
Why?
|
| Cerebral Cortex | 3 | 2024 | 5753 | 0.110 |
Why?
|
| Receptors, Glycine | 1 | 2013 | 32 | 0.110 |
Why?
|
| Trephining | 1 | 2013 | 18 | 0.110 |
Why?
|
| Meningitis | 1 | 2015 | 219 | 0.110 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2013 | 16 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3053 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2039 | 0.110 |
Why?
|
| Osmolar Concentration | 1 | 2014 | 655 | 0.110 |
Why?
|
| Dental Implants | 1 | 2021 | 790 | 0.110 |
Why?
|
| Glyburide | 1 | 2014 | 117 | 0.110 |
Why?
|
| Ependymoma | 1 | 2016 | 326 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2018 | 2510 | 0.110 |
Why?
|
| Cervical Vertebrae | 3 | 2023 | 978 | 0.110 |
Why?
|
| Hypernatremia | 1 | 2013 | 78 | 0.110 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2013 | 116 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1885 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1425 | 0.100 |
Why?
|
| Xenopus Proteins | 2 | 2008 | 435 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3582 | 0.100 |
Why?
|
| Guanine Nucleotides | 1 | 2012 | 55 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 4780 | 0.100 |
Why?
|
| Phenobarbital | 1 | 2013 | 192 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2019 | 1345 | 0.100 |
Why?
|
| Skull Fracture, Basilar | 1 | 2011 | 6 | 0.100 |
Why?
|
| Drug Design | 1 | 2017 | 1043 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 447 | 0.100 |
Why?
|
| Neurocytoma | 1 | 2011 | 28 | 0.100 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2011 | 43 | 0.100 |
Why?
|
| MELAS Syndrome | 1 | 2012 | 55 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2013 | 312 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 1608 | 0.090 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 85 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3610 | 0.090 |
Why?
|
| Petrous Bone | 1 | 2011 | 85 | 0.090 |
Why?
|
| Hernia | 1 | 2011 | 67 | 0.090 |
Why?
|
| Skull Base Neoplasms | 1 | 2015 | 280 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 2631 | 0.090 |
Why?
|
| Exons | 2 | 2016 | 2392 | 0.090 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 87 | 0.090 |
Why?
|
| Spina Bifida Occulta | 1 | 2011 | 31 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1889 | 0.090 |
Why?
|
| Meningocele | 1 | 2011 | 50 | 0.090 |
Why?
|
| Chondroblastoma | 1 | 2011 | 47 | 0.090 |
Why?
|
| Calcium | 1 | 2024 | 5783 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 1428 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2020 | 3723 | 0.090 |
Why?
|
| SEER Program | 1 | 2016 | 1444 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2017 | 13411 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2841 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1080 | 0.090 |
Why?
|
| Anemia | 1 | 2020 | 1514 | 0.090 |
Why?
|
| Mitochondria | 1 | 2024 | 3678 | 0.090 |
Why?
|
| Vertebral Artery | 1 | 2011 | 185 | 0.090 |
Why?
|
| Abscisic Acid | 1 | 2010 | 42 | 0.090 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2011 | 70 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2023 | 3079 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2012 | 566 | 0.090 |
Why?
|
| Caenorhabditis | 1 | 2010 | 39 | 0.090 |
Why?
|
| Tissue Expansion Devices | 2 | 2021 | 160 | 0.090 |
Why?
|
| Globus Pallidus | 1 | 2012 | 247 | 0.090 |
Why?
|
| Blood Gas Analysis | 1 | 2011 | 382 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2021 | 8065 | 0.090 |
Why?
|
| Genes, myc | 1 | 2011 | 391 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 3828 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 8623 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 11062 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1424 | 0.090 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.090 |
Why?
|
| Plant Roots | 1 | 2010 | 121 | 0.090 |
Why?
|
| Cell Line | 5 | 2014 | 15564 | 0.090 |
Why?
|
| Search Engine | 1 | 2011 | 142 | 0.080 |
Why?
|
| Blast Crisis | 1 | 2010 | 102 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2019 | 924 | 0.080 |
Why?
|
| Pituitary Diseases | 1 | 2011 | 137 | 0.080 |
Why?
|
| Multigene Family | 1 | 2013 | 1081 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2011 | 111 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2023 | 3591 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2011 | 348 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2010 | 161 | 0.080 |
Why?
|
| Purkinje Cells | 1 | 2011 | 228 | 0.080 |
Why?
|
| Genes, Lethal | 1 | 2010 | 224 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage, Traumatic | 1 | 2009 | 13 | 0.080 |
Why?
|
| Risk Factors | 7 | 2021 | 74889 | 0.080 |
Why?
|
| Spondylolisthesis | 1 | 2011 | 173 | 0.080 |
Why?
|
| Catheterization | 1 | 2014 | 1429 | 0.080 |
Why?
|
| Dacarbazine | 1 | 2012 | 552 | 0.080 |
Why?
|
| Antioxidants | 1 | 2017 | 1671 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1730 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 2 | 2020 | 2954 | 0.080 |
Why?
|
| Cystic Fibrosis | 2 | 2017 | 1285 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2021 | 3464 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 2561 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 264 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2002 | 616 | 0.080 |
Why?
|
| Epilepsy, Benign Neonatal | 1 | 2008 | 13 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 3759 | 0.080 |
Why?
|
| Skull Base | 1 | 2011 | 294 | 0.080 |
Why?
|
| Acute Disease | 2 | 2017 | 7240 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2744 | 0.080 |
Why?
|
| Colitis | 1 | 2017 | 1238 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2016 | 2669 | 0.080 |
Why?
|
| Chordoma | 1 | 2012 | 349 | 0.080 |
Why?
|
| Cytokines | 2 | 2021 | 7438 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 587 | 0.080 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2010 | 158 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2019 | 7869 | 0.080 |
Why?
|
| Genes, Essential | 1 | 2010 | 185 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2010 | 3587 | 0.080 |
Why?
|
| Vascular System Injuries | 1 | 2011 | 247 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 3427 | 0.080 |
Why?
|
| Hyponatremia | 1 | 2011 | 278 | 0.070 |
Why?
|
| Plant Proteins | 1 | 2010 | 376 | 0.070 |
Why?
|
| Cerebral Revascularization | 1 | 2011 | 260 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 1403 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 2056 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3702 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 3440 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2021 | 6258 | 0.070 |
Why?
|
| Heart | 1 | 2020 | 4425 | 0.070 |
Why?
|
| Glioblastoma | 3 | 2012 | 3458 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2017 | 1982 | 0.070 |
Why?
|
| Nerve Net | 1 | 2019 | 2307 | 0.070 |
Why?
|
| Dystonic Disorders | 1 | 2012 | 354 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 718 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2014 | 3624 | 0.070 |
Why?
|
| Craniocerebral Trauma | 1 | 2011 | 493 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2021 | 3967 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3230 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 605 | 0.070 |
Why?
|
| Steroids | 1 | 2012 | 936 | 0.070 |
Why?
|
| Kidney Tubules, Distal | 1 | 2006 | 43 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2021 | 3283 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2018 | 20710 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2011 | 968 | 0.070 |
Why?
|
| Endothelium | 1 | 2009 | 768 | 0.070 |
Why?
|
| Action Potentials | 1 | 2014 | 1835 | 0.070 |
Why?
|
| Vasospasm, Intracranial | 1 | 2009 | 207 | 0.070 |
Why?
|
| Endocytosis | 2 | 2017 | 951 | 0.070 |
Why?
|
| Prevalence | 3 | 2020 | 15835 | 0.070 |
Why?
|
| Protein Conformation | 1 | 2014 | 3948 | 0.070 |
Why?
|
| Prognosis | 3 | 2023 | 29959 | 0.070 |
Why?
|
| Bone Transplantation | 1 | 2011 | 921 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2012 | 630 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 996 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 1 | 2011 | 561 | 0.060 |
Why?
|
| Microvessels | 1 | 2010 | 586 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2009 | 843 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2010 | 1892 | 0.060 |
Why?
|
| Caregivers | 1 | 2018 | 2303 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 682 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10580 | 0.060 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 12985 | 0.060 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 163 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 947 | 0.060 |
Why?
|
| Freeze Fracturing | 1 | 2004 | 68 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2019 | 4926 | 0.060 |
Why?
|
| Alcoholism | 1 | 2016 | 1980 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2010 | 672 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1433 | 0.060 |
Why?
|
| Potassium Channels | 2 | 2007 | 534 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 1171 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2015 | 2978 | 0.060 |
Why?
|
| Time Factors | 5 | 2021 | 40149 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 39312 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2024 | 89 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 1492 | 0.060 |
Why?
|
| Biochemistry | 1 | 2005 | 115 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 444 | 0.060 |
Why?
|
| Patient Admission | 1 | 2011 | 1364 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3411 | 0.060 |
Why?
|
| Oncogenes | 1 | 2010 | 1232 | 0.060 |
Why?
|
| Geography | 2 | 2020 | 651 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2004 | 1989 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 415 | 0.060 |
Why?
|
| Transfection | 5 | 2017 | 5755 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2010 | 702 | 0.050 |
Why?
|
| Cell Survival | 2 | 2011 | 5749 | 0.050 |
Why?
|
| Electroencephalography | 3 | 2023 | 6282 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2010 | 1505 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4668 | 0.050 |
Why?
|
| Deep Brain Stimulation | 1 | 2012 | 850 | 0.050 |
Why?
|
| Bromides | 1 | 2022 | 22 | 0.050 |
Why?
|
| Dogs | 2 | 2005 | 3834 | 0.050 |
Why?
|
| Alleles | 1 | 2014 | 6896 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1407 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 1506 | 0.050 |
Why?
|
| Proteomics | 1 | 2016 | 3915 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 239 | 0.050 |
Why?
|
| Hemizygote | 1 | 2022 | 27 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5330 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9613 | 0.050 |
Why?
|
| Urothelium | 1 | 2004 | 275 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2014 | 17089 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2022 | 49 | 0.050 |
Why?
|
| Clathrin | 1 | 2003 | 258 | 0.050 |
Why?
|
| DNA Repair | 1 | 2011 | 2050 | 0.050 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 231 | 0.050 |
Why?
|
| Endoscopy | 1 | 2012 | 1854 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 6968 | 0.050 |
Why?
|
| Cell Movement | 1 | 2014 | 5204 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 4 | 2013 | 2671 | 0.050 |
Why?
|
| Water | 2 | 2023 | 1416 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2010 | 1063 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10451 | 0.050 |
Why?
|
| Rotarod Performance Test | 1 | 2021 | 63 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1677 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4892 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 839 | 0.050 |
Why?
|
| Neoplasms | 1 | 2010 | 22350 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2005 | 455 | 0.040 |
Why?
|
| Tissue Expansion | 1 | 2021 | 163 | 0.040 |
Why?
|
| Age Factors | 4 | 2021 | 18397 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1742 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 13644 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2022 | 699 | 0.040 |
Why?
|
| Nasal Cavity | 1 | 2022 | 310 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3459 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 4968 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2020 | 318 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10263 | 0.040 |
Why?
|
| Disease Progression | 3 | 2012 | 13642 | 0.040 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 54 | 0.040 |
Why?
|
| Esthetics, Dental | 1 | 2021 | 267 | 0.040 |
Why?
|
| United States | 4 | 2021 | 72945 | 0.040 |
Why?
|
| Pain | 2 | 2015 | 5098 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 2019 | 228 | 0.040 |
Why?
|
| Stents | 1 | 2011 | 3193 | 0.040 |
Why?
|
| Point Mutation | 1 | 2004 | 1592 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 8108 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3113 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2019 | 141 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 635 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4401 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 741 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2013 | 1757 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2011 | 3466 | 0.040 |
Why?
|
| Kyphosis | 1 | 2021 | 252 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 635 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2062 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4047 | 0.040 |
Why?
|
| Smad6 Protein | 1 | 2017 | 14 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7612 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7870 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6507 | 0.040 |
Why?
|
| Organogenesis | 1 | 2018 | 214 | 0.030 |
Why?
|
| Cell Death | 2 | 2013 | 1676 | 0.030 |
Why?
|
| COS Cells | 3 | 2005 | 1135 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11876 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 6965 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 17609 | 0.030 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 270 | 0.030 |
Why?
|
| Aged | 9 | 2021 | 171344 | 0.030 |
Why?
|
| Oximes | 1 | 2018 | 305 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22248 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 59548 | 0.030 |
Why?
|
| Drainage | 1 | 2022 | 1182 | 0.030 |
Why?
|
| Apoptosis | 1 | 2012 | 9514 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 859 | 0.030 |
Why?
|
| Mucorales | 1 | 2016 | 35 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2016 | 150 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 187 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 403 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2016 | 4143 | 0.030 |
Why?
|
| Rhizotomy | 1 | 2015 | 30 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2018 | 379 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2018 | 385 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2015 | 317 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 2017 | 447 | 0.030 |
Why?
|
| Incidence | 3 | 2021 | 21527 | 0.030 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 101 | 0.030 |
Why?
|
| Sodium Channels | 2 | 2007 | 339 | 0.030 |
Why?
|
| Cavernous Sinus | 1 | 2015 | 121 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2011 | 21162 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9244 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2017 | 960 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5890 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 496 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 1018 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6514 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 2014 | 240 | 0.030 |
Why?
|
| Siblings | 1 | 2017 | 828 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2021 | 1680 | 0.030 |
Why?
|
| Pyridones | 1 | 2018 | 818 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 110 | 0.020 |
Why?
|
| Compassionate Use Trials | 1 | 2012 | 50 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2017 | 838 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 545 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 1263 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 845 | 0.020 |
Why?
|
| ras Proteins | 1 | 2017 | 1055 | 0.020 |
Why?
|
| Aldosterone | 2 | 2007 | 881 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2004 | 12795 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2012 | 198 | 0.020 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2011 | 35 | 0.020 |
Why?
|
| Teaching | 1 | 2019 | 1171 | 0.020 |
Why?
|
| Butadienes | 2 | 2002 | 107 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5389 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2012 | 178 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 3600 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2012 | 194 | 0.020 |
Why?
|
| Consciousness Disorders | 1 | 2016 | 445 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2980 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1838 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2014 | 638 | 0.020 |
Why?
|
| Fetus | 1 | 2018 | 1878 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 1417 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2011 | 59 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2016 | 769 | 0.020 |
Why?
|
| Plants, Genetically Modified | 1 | 2010 | 113 | 0.020 |
Why?
|
| Age Distribution | 1 | 2016 | 2869 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3738 | 0.020 |
Why?
|
| Regeneration | 1 | 2019 | 1520 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2017 | 1282 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2012 | 616 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4325 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 201 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2012 | 329 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1319 | 0.020 |
Why?
|
| Bicycling | 1 | 2011 | 177 | 0.020 |
Why?
|
| Family | 1 | 2021 | 3209 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 730 | 0.020 |
Why?
|
| Prednisolone | 1 | 2011 | 326 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2010 | 209 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2022 | 3831 | 0.020 |
Why?
|
| Benzazepines | 1 | 2012 | 307 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2011 | 562 | 0.020 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2009 | 13 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 833 | 0.020 |
Why?
|
| Interneurons | 1 | 2014 | 592 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 1675 | 0.020 |
Why?
|
| Radiculopathy | 1 | 2011 | 202 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 2010 | 131 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 476 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2010 | 405 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1716 | 0.020 |
Why?
|
| Hypovolemia | 1 | 2009 | 48 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 8540 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 496 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2010 | 244 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3642 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 423 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2012 | 0.020 |
Why?
|
| Zebrafish | 1 | 2019 | 3035 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 272 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2011 | 462 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2629 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2013 | 9358 | 0.020 |
Why?
|
| Parents | 1 | 2021 | 3592 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2013 | 1050 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 872 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 125 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2020 | 3240 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 1176 | 0.020 |
Why?
|
| Temporal Bone | 1 | 2011 | 683 | 0.020 |
Why?
|
| Hypotonic Solutions | 1 | 2006 | 48 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2014 | 2201 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1606 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 818 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 7057 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 1164 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2005 | 167 | 0.020 |
Why?
|
| Arteries | 1 | 2011 | 1123 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 928 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 3485 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13489 | 0.020 |
Why?
|
| Electrolytes | 1 | 2006 | 279 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 2005 | 169 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3618 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 11924 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1865 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11657 | 0.010 |
Why?
|
| Pediatrics | 1 | 2020 | 3614 | 0.010 |
Why?
|
| Benzamides | 1 | 2010 | 1375 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 1349 | 0.010 |
Why?
|
| Heparin | 1 | 2011 | 1636 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2925 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 1446 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2010 | 1497 | 0.010 |
Why?
|
| Cerebellum | 1 | 2011 | 1520 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2391 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2011 | 1716 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1729 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6306 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 9407 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 736 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2010 | 1747 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2010 | 1077 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3681 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 4114 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2419 | 0.010 |
Why?
|
| Base Sequence | 2 | 2003 | 12415 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1805 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 2078 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 816 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13476 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1550 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 451 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 565 | 0.010 |
Why?
|
| Piperazines | 1 | 2010 | 2547 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 478 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 966 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2002 | 539 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 1065 | 0.010 |
Why?
|
| Colon | 1 | 2007 | 1797 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 6288 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2010 | 3043 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 8507 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2275 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 2746 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5344 | 0.010 |
Why?
|
| Thrombosis | 1 | 2011 | 2953 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1750 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2268 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15912 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54872 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6548 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9528 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14762 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12536 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 11218 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2001 | 0.010 |
Why?
|
| Smoking | 1 | 2011 | 9077 | 0.010 |
Why?
|
| Phylogeny | 1 | 2002 | 2840 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5690 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5990 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 5702 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12064 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13276 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9326 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15425 | 0.000 |
Why?
|